Venetoclax in Patients with Previously Treated Chronic Lymphocytic Leukemia

Erstveröffentlichung

2017

Authors

Roberts, Andrew W.

Stilgenbauer, Stephan

Seymour, John F.

Huang, David C. S.

Wissenschaftlicher Artikel

Published in

Clinical Cancer Research ; 23 (2017), 16. - S. 4527-4533. - ISSN 1078-0432. - eISSN 1557-3265

Link to publication

https://dx.doi.org/10.1158/1078-0432.CCR-16-0955

Institutions

UKU. Klinik für Innere Medizin III

DFG Project THU

SFB 1074 / Experimentelle Modelle und klinische Translation bei Leukämien / DFG / 217328187

Subject headings

[Free subject headings]: phase-2 trial | open-label | plus rituximab | subcutaneous alemtuzumab | antitumor-activity | bcl-2 inhibitor | transgenic mice | cell survival | 17p deletion | follow-up
[DDC subject group]: DDC 610 / Medicine & health

Metadata

Show full item record